Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

The effect of grape seed extract on estrogen levels of postmenopausal women: a pilot study.

Wahner-Roedler DL, Bauer BA, Loehrer LL, Cha SS, Hoskin TL, Olson JE.

J Diet Suppl. 2014 Jun;11(2):184-97. doi: 10.3109/19390211.2013.859220.

PMID:
24670122
[PubMed - in process]
2.

Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression.

Kijima I, Phung S, Hur G, Kwok SL, Chen S.

Cancer Res. 2006 Jun 1;66(11):5960-7.

PMID:
16740737
[PubMed - indexed for MEDLINE]
Free Article
3.

Breast cancer prevention--clinical trials strategies involving aromatase inhibitors.

Goss PE.

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):487-93. Review.

PMID:
14623548
[PubMed - indexed for MEDLINE]
4.

Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo.

Freedman M, San Martin J, O'Gorman J, Eckert S, Lippman ME, Lo SC, Walls EL, Zeng J.

J Natl Cancer Inst. 2001 Jan 3;93(1):51-6.

PMID:
11136842
[PubMed - indexed for MEDLINE]
Free Article
5.

Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.

Saitta A, Altavilla D, Cucinotta D, Morabito N, Frisina N, Corrado F, D'Anna R, Lasco A, Squadrito G, Gaudio A, Cancellieri F, Arcoraci V, Squadrito F.

Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1512-9.

PMID:
11557681
[PubMed - indexed for MEDLINE]
Free Article
6.

Phase 3 trials of aromatase inhibitors for breast cancer prevention: following in the path of the selective estrogen receptor modulators.

Dunn BK, Ryan A.

Ann N Y Acad Sci. 2009 Feb;1155:141-61. doi: 10.1111/j.1749-6632.2009.03688.x. Review.

PMID:
19250201
[PubMed - indexed for MEDLINE]
7.

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, Garber J, Vogel VG, Wade JL, Brown P, Cuzick J, Kramer BS, Lippman SM; American Society of Clinical Oncology.

J Clin Oncol. 2009 Jul 1;27(19):3235-58. doi: 10.1200/JCO.2008.20.5179. Epub 2009 May 26.

PMID:
19470930
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Transition from estrogen therapy to raloxifene in postmenopausal women: effects on treatment satisfaction and the endometrium-a pilot study.

Davis SR, O'Neill SM, Eden J, Baber R, Ekangaki A, Stocks JM, Thiebaud D.

Menopause. 2004 Mar-Apr;11(2):167-75.

PMID:
15021446
[PubMed - indexed for MEDLINE]
9.

Evaluation of the Aromatase Inhibition Potential of Freeze-Dried Grape Powder.

Allen SV, Pruthi S, Suman VJ, Hoskin TL, Vachon CM, Ingle JN, Olson JE.

J Diet Suppl. 2014 Aug 28. [Epub ahead of print]

PMID:
25167077
[PubMed - as supplied by publisher]
10.

Molecular Action and Clinical Relevance of Aromatase Inhibitors.

Murphy MJ Jr.

Oncologist. 1998;3(2):129-130.

PMID:
10388095
[PubMed - as supplied by publisher]
Free Article
11.

[Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects].

de Cremoux P, Diéras V, Poupon MF, Magdelénat H, Sigal-Zafrani B, Fourquet A, Pierga JY.

Bull Cancer. 2004 Dec;91(12):917-27. Review. French.

PMID:
15634633
[PubMed - indexed for MEDLINE]
12.

The role of aromatase inhibitors in early breast cancer.

Chung CT, Carlson RW.

Curr Treat Options Oncol. 2003 Apr;4(2):133-40. Review.

PMID:
12594939
[PubMed - indexed for MEDLINE]
13.

The benefits of estrogen or selective estrogen receptor modulator on kidney and its related disease-chronic kidney disease-mineral and bone disorder: osteoporosis.

Lee WL, Cheng MH, Tarng DC, Yang WC, Lee FK, Wang PH.

J Chin Med Assoc. 2013 Jul;76(7):365-71. doi: 10.1016/j.jcma.2013.03.010. Epub 2013 May 9. Review.

PMID:
23664736
[PubMed - indexed for MEDLINE]
14.
15.

Hormone therapy for sexual function in perimenopausal and postmenopausal women.

Nastri CO, Lara LA, Ferriani RA, Rosa-E-Silva AC, Figueiredo JB, Martins WP.

Cochrane Database Syst Rev. 2013 Jun 5;6:CD009672. doi: 10.1002/14651858.CD009672.pub2. Review.

PMID:
23737033
[PubMed - indexed for MEDLINE]
16.

Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women.

Goss PE, Hadji P, Subar M, Abreu P, Thomsen T, Banke-Bochita J.

Breast Cancer Res. 2007;9(4):R52.

PMID:
17692126
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials.

Feringa HH, Laskey DA, Dickson JE, Coleman CI.

J Am Diet Assoc. 2011 Aug;111(8):1173-81. doi: 10.1016/j.jada.2011.05.015. Review.

PMID:
21802563
[PubMed - indexed for MEDLINE]
18.

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.

Regan MM, Neven P, Giobbie-Hurder A, Goldhirsch A, Ejlertsen B, Mauriac L, Forbes JF, Smith I, Láng I, Wardley A, Rabaglio M, Price KN, Gelber RD, Coates AS, Thürlimann B; BIG 1-98 Collaborative Group; International Breast Cancer Study Group (IBCSG).

Lancet Oncol. 2011 Nov;12(12):1101-8. doi: 10.1016/S1470-2045(11)70270-4. Epub 2011 Oct 20.

PMID:
22018631
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.

Geisler J.

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):245-53. Review.

PMID:
14623518
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk